HOME >> BIOLOGY >> NEWS
EPA foregoes opportunity to improve nanotechnology oversight

WASHINGTON, DCThe U.S. Environmental Protection Agency released its current thinking on whether a nanoscale material is a new or existing chemical substance under the Toxic Substances Control Act (TSCA). In the document, TSCA Inventory Status of Nanoscale SubstancesGeneral Approach, EPA states that it will maintain its practice of determining whether nanoscale substances qualify as new chemicals under TSCA on a case-by-case basis.

According to former EPA official and Project on Emerging Nanotechnologies (PEN) senior advisor J. Clarence Davies, The agencys current practice is inadequate to deal with nanotechnology. It is essential that EPA move quickly to recognize the novel biological and ecological characteristics of nanoscale materials. It can do this only by using the new uses provisions of TSCA, a subject not mentioned in the EPAs inventory document. With the approach outlined by EPA and because of the weaknesses in the law, the agency is not even able to identify which substances are nanomaterials, much less determine whether they pose a hazard.

Project on Emerging Nanotechnologies science advisor Andrew Maynard underlined that EPAs approach ignores the scientific research evidence to date that different nanostructures with the same molecular identity present different hazards. Nanotechnology is a rapidly growing sector of the economy that will represent an estimated $2.6 trillion in manufactured goods by 2014, or about 15 percent of global manufactured goods output.

In addition to the TSCA document, the agency issued papers for public comment pertaining to a proposed voluntary industry Nanoscale Materials Stewardship Program (NMSP)an effort to encourage industry to provide the agency on a voluntary basis with scientific information about the risk management practices now used by manufacturers of existing nanomaterials.

Starting the Stewardship program will be a positive step toward filling in some of the informati
'"/>

Contact: Julia Moore
julia.moore@wilsoncenter.org
202-691-4025
Project on Emerging Nanotechnologies
12-Jul-2007


Page: 1 2 3

Related biology news :

1. SNM capitalizes opportunity to meet with policymakers, regulators at annual meeting in D.C.
2. Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development
3. Not-for-profit publishers call NIH public access rule a missed opportunity
4. The opportunity for canalization and the evolution of genetic networks
5. New test improves detection of liver cancer
6. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
7. Gene expression pattern could lead to improved treatment of pediatric septic shock
8. Additional mammogram readers improve breast cancer detection
9. New role for protein in fat cells may improve understanding of obesity and diabetes
10. Jefferson scientists patent dramatically improves
11. Cardiac patches stimulate regeneration, improve function after heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval ... CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned a ... The company’s solutions are the first Wharton’s jelly allograft product to be recognized as ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... , ... August 13, 2020 , ... True Terpenes ... creation of its Scientific Advisory Board (SAB) to research the medical potential of terpenes ... be enhanced when combined with terpenes. The board is focused on expanding the recently ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON ... of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes ... globe, requiring fast track capacity to provide patients with urgently needed vaccines and ...
Breaking Biology Technology:
Cached News: